These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38004567)

  • 1. Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design.
    Rouaz-El-Hajoui K; García-Montoya E; López-Urbano A; Romero-Obon M; Chiclana-Rodríguez B; Fraschi-Nieto A; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pellets and gummies: Seeking a 3D printed gastro-resistant omeprazole dosage for paediatric administration.
    Rouaz-El Hajoui K; Herrada-Manchón H; Rodríguez-González D; Fernández MA; Aguilar E; Suñé-Pou M; Nardi-Ricart A; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2023 Aug; 643():123289. PubMed ID: 37536640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
    He W; Fan LF; Du Q; Xiang B; Li CL; Bai M; Chang YZ; Cao DY
    Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):122-8. PubMed ID: 19182399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.
    Riedel A; Leopold CS
    Drug Dev Ind Pharm; 2005 Jan; 31(2):151-60. PubMed ID: 15773282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
    Thoma K; Bechtold K
    Eur J Pharm Biopharm; 1999 Jan; 47(1):39-50. PubMed ID: 10234526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): A rapid test for enteric coating thickness and integrity of controlled release pellet formulations.
    Alfarsi A; Dillon A; McSweeney S; Krüse J; Griffin B; Devine K; Sherry P; Henken S; Fitzpatrick S; Fitzpatrick D
    Int J Pharm; 2018 Jun; 544(1):31-38. PubMed ID: 29655796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
    Bendas ER; Abdelbary AA
    Int J Pharm; 2014 Jul; 468(1-2):97-104. PubMed ID: 24746414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
    Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
    AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of capsules containing omeprazole in enteric coated pellets.
    Palummo M; Cingolani A; Dall L; Volonté MG
    Boll Chim Farm; 2000; 139(3):124-8. PubMed ID: 10961022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding.
    Wells KA; Losin WG
    Clin Ther; 2008 Jul; 30(7):1300-8. PubMed ID: 18691989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tableting and stability evaluation of enteric-coated omeprazole pellets.
    Türkoğlu M; Varol H; Celikok M
    Eur J Pharm Biopharm; 2004 Mar; 57(2):279-86. PubMed ID: 15018985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
    Kranz H; Gutsche S
    Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state interactions at the core-coat interface: physicochemical characterization of enteric-coated omeprazole pellets without a protective sub-coat.
    Sharma VD; Akocak S; Ilies MA; Fassihi R
    AAPS PharmSciTech; 2015 Aug; 16(4):934-43. PubMed ID: 25595125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.
    Riedel A; Leopold CS
    Pharmazie; 2005 Feb; 60(2):126-30. PubMed ID: 15739901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs.
    Cui C; Sun J; Wang X; Yu Z; Shi Y
    Dose Response; 2020; 18(1):1559325820908980. PubMed ID: 32180688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery.
    Raval MK; Ramani RV; Sheth NR
    Int J Pharm Investig; 2013 Oct; 3(4):203-11. PubMed ID: 24350040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
    Avachat AM; Shinde AS
    Drug Dev Ind Pharm; 2016 Jan; 42(1):80-90. PubMed ID: 25923416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.